Slt2p (also known as Mitogen-Activated Protein Kinase 1, MAPK1) is a critical component of the cell wall integrity (CWI) pathway in yeast and related organisms. It regulates cellular responses to stress, oxidative damage, and cell wall remodeling through phosphorylation cascades . Antibodies targeting Slt2p are essential research tools for studying its role in signaling pathways, protein interactions, and stress responses.
Slt2p operates within a kinase cascade involving upstream activators (Bck1p, Mkk1/2p) and downstream transcription factors (Rlm1p, Swi4/6p). Key functions include:
Stress Response Regulation: Slt2p phosphorylates substrates like cyclin C under oxidative stress (H₂O₂), triggering its nuclear-to-cytoplasmic translocation and modulating apoptosis .
mRNA Stability Control: Slt2p attenuates RNA-binding protein Rbp1p activity, stabilizing cell wall repair mRNAs (e.g., SED1, BGL2) during stress .
Cell Cycle Coordination: Slt2p interacts with cyclin C, influencing mitochondrial-dependent programmed cell death (PCD) .
Antibodies against Slt2p or epitope-tagged Slt2p (e.g., HA-tagged) enable critical discoveries:
Immunoprecipitation: Anti-HA antibodies isolate Slt2p-HA complexes to study interacting partners (e.g., cyclin C) .
Western Blotting: Detects Slt2p phosphorylation states under stress conditions .
Functional Assays: Links kinase activity to mRNA stability and apoptosis .
While Slt2p antibodies are primarily research tools, understanding Slt2p signaling informs:
Antifungal Drug Design: Targeting CWI pathways to disrupt pathogen cell walls.
Cancer Research: Analogous MAPK pathways in humans (e.g., ERK1/2) are oncogenic targets.
Specificity: Commercial Slt2p antibodies require validation for yeast vs. human homolog cross-reactivity.
Functional Studies: Live-cell imaging and CRISPR-edited models could refine Slt2p’s role in stress adaptation.